CheckMyRecalls

Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood…

Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality control

Published
24 Jun 2026
Units affected
6060
Agency
FDA
Country
United States

The hazard

Assayed Whole blood control contains labeling with incorrect performance range.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2

Brand / company
Accriva Diagnostics, Inc.
Codes / lots
Lot #: A6DLA001 Unique Device Identifier: 10711234170373
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.